Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
59.05
+0.45 (0.77%)
Aug 7, 2026, 1:03 PM CET

BME:ROVI Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
773.05743.48763.75829.51817.7648.68
Revenue Growth
3.21%-2.65%-7.93%1.44%26.06%54.46%
Gross Profit
615.62482.03477.7488.42516.76384.82
Operating Income
134.84185.84179.4220.13255.85181.57
Net Income
185.18140.44136.88170.34199.67153.08
Earnings Per Share
3.622.752.673.203.732.76
EPS Growth
40.02%3.00%-16.56%-14.21%35.14%150.91%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing
513.22494.13600.35644.41619.23471.79
Other
0.140.1----
Inter-Segment Transactions
-214.59-224.63-264.13-235.13-215.69-207.09
Marketing
474.29473.89427.53420.23414.15383.98
Total
773.05743.48763.75829.51817.7648.68

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
128.0797.9827.4125.32124.9599.04
Total Debt
107.69121.82114.4165.4372.170.71
Net Cash (Debt)
20.38-23.85-87-40.1152.7898.32
Net Cash Growth
-----46.32%-
Net Cash Per Share
0.40-0.47-1.70-0.750.991.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
167.6444.5251.6754.2237.6149.44
Capital Expenditures
-45.87-8.16-3.39-5.5-50.72-40.22
Free Cash Flow
121.7736.3648.2848.7186.88109.22
Free Cash Flow Growth
326.94%-24.69%-0.87%-73.94%71.10%1348.77%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.63%64.83%62.55%58.88%63.20%59.32%
Operating Margin
17.44%25.00%23.49%26.54%31.29%27.99%
Pretax Margin
30.43%24.65%23.27%26.57%31.55%28.15%
Profit Margin
23.94%18.88%17.92%20.53%24.42%23.60%
FCF Margin
15.75%4.89%6.32%5.87%22.85%16.84%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9590.9590.9351.1041.2940.956
Dividend Per Share Growth
2.60%2.60%-15.28%-14.69%35.39%150.68%
Dividend Yield
1.64%2.95%3.50%4.31%2.65%0.52%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.1823.0923.5818.819.6726.74
Forward PE
20.0521.5819.0219.7612.7625.70
P/FCF Ratio
16.7189.3366.6964.0510.3037.46
PS Ratio
3.884.374.223.762.356.31